Full-Time
Posted on 9/30/2025
SaaS revenue management for life sciences
No salary listed
Hyderabad, Telangana, India
In Person
| , |
Model N provides cloud-based revenue management software for the high-tech and life sciences industries. It offers industry-specific SaaS solutions, including Revenue Cloud for Pharma, Revenue Cloud for Medtech, and Revenue Cloud for High Tech, to manage pricing, quote-to-cash, channel partner engagement, global pricing, tender management, and revenue recognition. The platform supports provider and payer relationships and helps customers navigate regulatory requirements while speeding up product launches. What sets Model N apart is its focus on industry-specific needs—combining regulatory compliance, pricing and contract management, and revenue optimization in one cloud-based system, backed by evidence of substantial client savings (an average of $68 million per $1 billion in revenue). The company’s goal is to help customers bring life-changing products to market faster and maximize revenue throughout commercialization, from pricing and quotes to global launches and ongoing compliance.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
San Mateo, California
Founded
1999
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Flexible Work Hours
401(k) Company Match
Paid Vacation
Life Insurance
Pet Insurance
Employee Assistance Programs
Mental Health Support
Employee Stock Purchase Plan
Professional Development Budget
Model N expands into global market access through strategic partnership with CCX. Joint offering helps life sciences companies align launch strategy and commercial decisions across global markets REDWOOD CITY, Calif. - March 2, 2026 - Model N, the leading end-to-end commercialization, revenue optimization, and compliance platform for life sciences companies, announced a strategic partnership with CCX, a market leading technology company focused on accelerating global market access and pricing strategy. The partnership extends Model N's platform functionality into earlier phases of the drug lifecycle and expands the company's capabilities beyond pricing and market access operations into global launch pricing strategy. As a result, joint customers can more effectively coordinate pricing strategies and ensure timely launch execution in an increasingly complex regulatory and market access environment. The collaboration enables pharmaceutical manufacturers to quickly model, simulate, and coordinate launch strategies and commercial terms before products reach the market - a critical need as early access decisions can have downstream pricing and revenue implications across global markets. Model N's 2026 State of Revenue Report found that 99% of life sciences leaders say gross-to-net has become more complex. Yet many organizations still manage critical pricing and revenue processes through spreadsheets and manual workflows. This limits their ability to quickly evaluate trade-offs, anticipate cross-market impacts, and identify pricing risks from policies such as most-favored-nation (MFN) before decisions are made. "As gross-to-net complexity continues to rise, life sciences organizations need earlier alignment across market access, global pricing, and revenue planning," said Bret Connor, CEO of Model N. "Market access decisions shape the long-term revenue trajectory of a therapy, and by partnering with CCX, we're extending Model N's platform into global launch planning and strategy. This gives our customers greater visibility from initial market access discussions through execution and revenue management." By combining CCX's market access planning capabilities with Model N's pricing, tender, and revenue management solutions, manufacturers can align strategy across the product lifecycle and support end-to-end commercialization through launch, contracting, and loss of exclusivity. Under the partnership, CCX technology connects directly to Model N's global pricing and tender solutions. This allows manufacturers to model cross-market launch sequencing, evaluate MFN exposure, reference pricing impacts, and assess trade-offs before implementation using data-driven scenario modeling. The integration connects market access planning with contracting, tender management, and rebate processing within a coordinated framework. CCX's platform supports in the moment scenario modeling for launch and loss-of-exclusivity planning, collaboration between headquarters and affiliates, and structured payer negotiations. The company currently supports 76 pharmaceutical assets across 56 countries. "By working with Model N, we can connect market access planning directly to revenue execution," said Nathan Sigworth, CEO of CCX. "Together, we are helping manufacturers launch products more strategically, manage commercial decisions with greater confidence, and foster stronger collaboration with payers to ensure therapies reach the patients who need them." Editor details. * Company: * PharmiWeb * Name: * Editor Last Updated: 04-Mar-2026
Model N, a commercialisation and revenue optimisation platform for life sciences and high-tech companies, has appointed Dan Koellhofer as chief product officer and David Schur as chief technology officer. The move separates product and technology functions to accelerate innovation whilst maintaining platform reliability as the company scales. Koellhofer, formerly SVP of applications for sales and marketing at Anaplan, will lead product strategy and innovation. Schur, previously CTO at Blackstone portfolio company Sphera, will oversee engineering and platform strategy, including new agentic AI capabilities. The appointments follow recent additions to Model N's executive team, including a chief growth officer, chief financial officer and chief customer officer. The California-based company serves over 150 manufacturers across more than 120 countries.
AVIZVA, a health-tech organization that offers a variety of solutions for healthcare enterprises, that it has appoints James Vertino as its new CEO.Model N appoints Bret Connor as Chief Executive Officer. The Board of Directors of Blue Shield of California appoints Lois Quam as chief executive officer to lead Blue Shield of California, the first woman to serve as CEO in the health plan’s 86-year history. She joined the company as president in 2024. Yaqrit, a late-stage biotech and medtech company developing lifesaving treatments for advanced liver diseases appoints Troels Jordansen has joined Yaqrit as Chief Executive Officer.OP Solutions names Michael Kallish as Chief Executive Officer, effective immediately.Access TeleCare appoints Dr. Michael Genovese to Chief Medical Officer for Behavioral Health.Enveda appoints Jason Kim as Chief Financial Officer (CFO).Eko Health appoints of Justin Spencer as Chief Financial Officer (CFO). (Pull from site)Qure.ai appoints Jim Mercadante as its new Chief Commercial Officer. (Pull from site)Symplr, appoints Dr
Model N has appointed Bret Connor as Chief Executive Officer.
Model N Appoints Bret Connor as CEO to Drive Next Phase of Growth. by Healthcare Executive Hires 01/06/2025 Leave a Comment. Bret Connor, CEO at Model NWhat You Should Know: – Model N, a leading provider of revenue optimization and compliance solutions for life sciences and high-tech companies, announced the appointment of Bret Connor as Chief Executive Officer. – Connor brings a wealth of experience in driving customer success and operational excellence, positioning Model N for continued growth and market leadership. Bret Connor Bio/BackgroundConnor joins Model N from athenahealth, where he served as Chief Operating Officer. During his tenure, he played a key role in the company’s transition to private ownership and spearheaded initiatives focused on client satisfaction and operational excellence. Under his leadership, athenahealth achieved record-high Net Promoter Scores and client retention rates, culminating in a successful recapitalization for $17 billion in 2022. He previously held executive roles at VMware, leading their Professional Services business in the Americas